Article

Increased CCL2/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC/BCL2 double-expressor diffuse large B-cell lymphoma

2024-04-10

Abstract excerpt

<title>Abstract</title> <p>The pathogenesis of MYC and BCL2 double expressor diffuse large B-cell lymphoma (DE-DLBCL) remains unclear. To investigate how MYC and BCL2 contribute to tumor aggressiveness, we analyzed tumors from 14 patients each with DE- and non-DE-DLBCL patients by whole transcriptome sequencing. Validation was performed using publicly available datasets, tumor tissues from 126 patients, DLBCL cel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a80f5826-3216-5143-977f-6daafe13186e
DOI: 10.21203/rs.3.rs-4220323/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Increased CCL2/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC/BCL2 double-expressor diffuse large B-cell lymphomaDOI 10.21203/rs.3.rs-4220323/v1Read

CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironmentSemantic proximity Read

Identification and validation of M2 macrophage-related differential genes in DLBCLSemantic proximity Read

Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphomaSemantic proximity Read

Identification of M2 macrophage-related genes associated with diffuse large B-cell lymphoma via bioinformatics and machine learning approachesSemantic proximity Read

Double-hit lymphomas: current paradigms and novel treatment approaches.Semantic proximity Read

The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma.Semantic proximity Read

Double hit diffuse large B-cell lymphomas: diagnostic and therapeutic challenges.Semantic proximity Read

Distinct Genetically Determined Origins of Myd88 / BCL2 -Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesSemantic proximity Read

MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical managementSemantic proximity Read

Double-Hit Large B Cell Lymphoma.Semantic proximity Read

MDM2-P53 Signaling Pathway-Mediated Upregulation of CDC20 Promotes Progression of Human Diffuse Large B-Cell LymphomaSemantic proximity Read

MYC‐associated and double‐hit lymphomas: A review of pathobiology, prognosis, and therapeutic approachesSemantic proximity Read